1-5 of 5
Dean Margeson, MAS
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Mutations In the Tet Oncogene Family Member 2 ( TET2 ) Gene Refine the New European LeukemiaNet Risk Classification of Primary, Cytogenetically Normal Acute Myeloid Leukemia (CN-AML) In Adults: A Cancer and Leukemia Group B (CALGB) Study

Klaus H. Metzeler, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Dean Margeson, MAS, Heiko Becker, MD, John Curfman, Kelsi B. Holland, MS, Sebastian Schwind, MD, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, William Blum, MD, Bayard L. Powell, MD, Thomas H. Carter, MD, PhD, Meir Wetzler, MD, Joseph O. Moore, MD, Jonathan E. Kolitz, MD, Maria R. Baer, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Michael A. Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2010) 116 (21): 98.
https://doi.org/10.1182/blood.V116.21.98.98
Published: 2010
Journal Articles

Sole Trisomy 8 In Patients (pts) with De Novo Acute Myeloid Leukemia (AML) Is Associated with Age-Independent Poor Outcome That Is Modified by Molecular Markers and with Unique Gene- and Microrna (miR)-Signatures: a Cancer and Leukemia Group B (CALGB) Study

Heiko Becker, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Dean Margeson, MAS, Krzysztof Mrózek, MD, PhD, Susan P. Whitman, PhD, Yue-Zhong Wu, MS, Klaus H. Metzeler, MD, Sebastian Schwind, MD, Kelsi B. Holland, MS, Jonathan E. Kolitz, MD, Andrew J. Carroll, PhD, Michael A. Caligiuri, MD, Maria R. Baer, MD, Richard A. Larson, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2010) 116 (21): 577.
https://doi.org/10.1182/blood.V116.21.577.577
Published: 2010
Journal Articles

Adverse Prognostic Impact of FLT3 Internal Tandem Duplication (ITD) Is Age-Associated in Older [≥60 Years (Y)] De Novo cytogenetically Normal Acute Myeloid Leukemia (CN-AML) Patients (Pts): a Cancer and Leukemia Group B (CALGB) Study.

Susan P. Whitman, PhD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Dean Margeson, MAS, Kelsi B. Holland, MS, Heiko Becker, MD, Yue-Zong Wu, MS, Sebastian Schwind, MD, Maria R Baer, MD, Bayard L. Powell, MD, Richard M Stone, MD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Michael A. Caligiuri, MD, Guido Marcucci, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2009) 114 (22): 1579.
https://doi.org/10.1182/blood.V114.22.1579.1579
Published: 2009
Journal Articles

Comparison of Clinical and Biologic Significance of WT1 Mutations in Populations of Older (≥60 years[y]) and Younger (<60 y) Adult Patients (Pts) with Cytogenetically Normal (CN) De Novo Acute Myeloid Leukemia (AML): a Cancer and Leukemia Group B (CALGB) Study.

Heiko Becker, MD, Guido Marcucci, MD, Kati Maharry, MAS, Michael D. Radmacher, PhD, Krzysztof Mrózek, MD, PhD, Susan P. Whitman, PhD, Peter Paschka, MD, Dean Margeson, MAS, Yue-Zhong Wu, MS, Sebastian Schwind, MD, Christian Langer, MD, Maria R. Baer, MD, Andrew J. Carroll, PhD, Michael A. Caligiuri, MD, Jonathan E. Kolitz, MD, Richard A. Larson, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2009) 114 (22): 326.
https://doi.org/10.1182/blood.V114.22.326.326
Published: 2009
Journal Articles

Prognostic Significance of Unbalanced Chromosome Abnormalities Used by 2008 World Health Organization (WHO) Classification to Define “Acute Myeloid Leukemia (AML) with Myelodysplasia-Related Changes” in Adults: a Cancer and Leukemia Group B (CALGB) Study.

Krzysztof Mrózek, MD, PhD, Kelsi B. Holland, MS, Mark J. Pettenati, PhD, Kati Maharry, MAS, Guido Marcucci, MD, Maria R. Baer, MD, Jonathan E. Kolitz, MD, Dean Margeson, MAS, Colin G. Edwards, PhD, Andrew J. Carroll, PhD, Richard A. Larson, MD, Clara D. Bloomfield, MD
Journal: Blood
Blood (2009) 114 (22): 2602.
https://doi.org/10.1182/blood.V114.22.2602.2602
Published: 2009